Additionally, a study of melanoma patients receiving ipilimumab treatment showed that lower levels of circulating IL-6, IL-8 and sCD25 at baseline were significantly correlated with a higher incidences of colitis [91]. The gene discussed is IL6; the disease is melanoma.